Rose-John; Stefan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rose-John; Stefan.The latest application filed is for "ciliary neurotrophic factor variants".
- Rose-John; Stefan - Schellhorn DE
- Rose-John; Stefan - Schelhorn DE
- Rose-John; Stefan - Kiel DE
- Rose-John; Stefan - Mainz DE
| Patent | Date |
|---|---|
| Treatment of obesity Grant 9,765,129 - Febbraio , et al. September 19, 2 | 2017-09-19 |
| Ciliary neurotrophic factor variants Grant 9,187,542 - Grotzinger , et al. November 17, 2 | 2015-11-17 |
| Ciliary Neurotrophic Factor Variants App 20140171620 - Grotzinger; Joachim ; et al. | 2014-06-19 |
| Treatment Of Obesity App 20140140949 - Febbraio; Mark Anthony ; et al. | 2014-05-22 |
| Soluble Gp130 Muteins With Improved Binding Activity App 20140072984 - Grotzinger; Joachim ; et al. | 2014-03-13 |
| Soluble GP130 muteins with improved binding activity Grant 8,501,696 - Grotzinger , et al. August 6, 2 | 2013-08-06 |
| Methods for the treatment of radiation or chemotherapy-induced tissue damage Grant 8,372,389 - Axelrod , et al. February 12, 2 | 2013-02-12 |
| Optimized nucleotide sequences encoding sgp130 Grant 8,206,948 - Seegert , et al. June 26, 2 | 2012-06-26 |
| Methods For The Treatment Of Radiation Or Chemotherapy-induced Tissue Damage App 20110184220 - Axelrod; Jonathan H. ; et al. | 2011-07-28 |
| Methods for the treatment of renal failure Grant 7,897,145 - Axelrod , et al. March 1, 2 | 2011-03-01 |
| Soluble Gp130 Muteins With Improved Binding Activity App 20100298236 - Grotzinger; Joachim ; et al. | 2010-11-25 |
| Treatment Of Obesity App 20100209385 - Febbraio; Mark Anthony ; et al. | 2010-08-19 |
| Methods For The Treatment Of Renal Failure App 20100135952 - Axelrod; Jonathan ; et al. | 2010-06-03 |
| PEGylated soluble GP130-dimers useful as a medicament Grant 7,629,147 - Seegert , et al. December 8, 2 | 2009-12-08 |
| PEGylated soluble gp130-dimers useful as a medicament Grant 7,534,862 - Seegert , et al. May 19, 2 | 2009-05-19 |
| Chimeric soluble hyper il-11 and use thereof App 20090010872 - Mackiewicz; Andrzej ; et al. | 2009-01-08 |
| Pegylated Soluble Gp130-dimers Useful As A Medicament App 20080227155 - Seegert; Dirk ; et al. | 2008-09-18 |
| Optimized Nucleotide Sequences Encoding Sgp 130 App 20080199906 - Seegert; Dirk ; et al. | 2008-08-21 |
| Pegylated Soluble Gp130-Dimers Useful as a Medicament App 20070270334 - Seegert; Dirk ; et al. | 2007-11-22 |
| Conjugate for modifying interactions between proteins Grant 7,112,436 - Rose-John September 26, 2 | 2006-09-26 |
| Compositions and methods for treating cancer with an oncolytic viral agent App 20050238622 - Axelrod, Jonathan H. ; et al. | 2005-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 